The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Abstract
The design of a human immunodeficiency virus–1 (HIV-1) immunogen that can induce broadly reactive neutralizing antibodies is a major goal of HIV-1 vaccine development. Although rare human monoclonal antibodies (mAbs) exist that broadly neutralize HIV-1, HIV-1 envelope immunogens do not induce these antibody specificities. Here we demonstrate that the two most broadly reactive HIV-1 envelope gp41 human mAbs, 2F5 and 4E10, are polyspecific autoantibodies reactive with the phospholipid cardiolipin. Thus, current HIV-1 vaccines may not induce these types of antibodies because of autoantigen mimicry of the conserved membrane-proximal epitopes of the virus. These results may have important implications for generating effective neutralizing antibody responses by using HIV-1 vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 985
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 576
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Self-citationDelgado Alves, J., Ames, P. R. J., Donohue, S., Stanyer, L., Noorouz‐Zadeh, J., Ravirajan, C., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10542 · Cited by 199
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Barbato, G., Bianchi, E., Ingallinella, P., Hurni, W. H., Miller, M. D., Ciliberto, G., Cortese, R., Bazzo, R., Shiver, J. W., & Pessi, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00611-9 · Cited by 136
Petrovas, C., Vlachoyiannopoulos, P. G., Kordossis, T., & Moutsopoulos, H. Μ. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0324 · Cited by 103
McGaughey, G. B., Citron, M. P., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M. D., Shiver, J. W., et al. (2003) · Biochemistry · doi:10.1021/bi026952u · Cited by 103
Loizou, S., Singh, S., Wypkema, E., & Asherson, R. A. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1106 · Cited by 87
Bouvet, J., & Dighiero, G. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.1-4.1998 · Cited by 86
Zhu, M., Olee, T., Le, D. T., Roubey, R. A. S., Hahn, B. H., Woods, V. L., & Chen, P. P. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01292.x · Cited by 79
Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis
Fenger, M., Wiik, A. S., Høier‐Madsen, M., Lykkegaard, J. J., Rozenfeld, T., Hansen, M. S., Danneskiold‐Samsøe, B., & Jacobsen, S. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038422 · Cited by 77
Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders
Guerin, J., Smith, O. P., White, B. C., Sweetman, G., Feighery, C., & Jackson, J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00876.x · Cited by 34
Kunert, R., Weik, R., Ferko, B., Stiegler, G. M., & Katinger, H. W. D. (2002) · AIDS · doi:10.1097/00002030-200203080-00020 · Cited by 28
Self-citationDouvas, A. S., TAKEHANA, Y., Ehresmann, G. R., CHERNYOVSKIY, T., & Daar, E. S. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.1509 · Cited by 28
Weiss, L., You, J. F., Giral, P., Alhenc‐Gelas, M., Senger, D., & Kazatchkine, M. D. (1995) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(95)90138-8 · Cited by 22
Cited by
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
Broad neutralization coverage of HIV by multiple highly potent antibodies
Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J.-P., Wang, S.-K., Ramos, A., Chan-Hui, P.-Y., Moyle, M., et al. (2011) · Nature · doi:10.1038/nature10373 · Cited by 1,480
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationBroad and potent neutralization of HIV-1 by a gp41-specific human antibody
Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., et al. (2012) · Nature · doi:10.1038/nature11544 · Cited by 828
Self-citation
Metadata
- Authors
- Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., Ortel, T. L., Liao, H.-X., & Alam, S. M.
- Venue
- Science
- Published
- 2005-06-24
- Volume
- 308
- Issue
- 5730
- Pages
- 1906-1908
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2097594050
- Cited by
- 744
- References
- 18
- FWCI
- 15.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.